Comprehensive Efficacy of the Dipeptidyl Peptidase 4 Inhibitor Alogliptin in Practical Clinical Settings: A Prospective Multi-Center Interventional Observational Study

BACKGROUND: This study aimed to verify the safety and efficacy, including glycemic control, of the selective dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes. METHODS: This study used a multi-center, open-label, prospective observational design. Type 2 diabetes patients w...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Med Res
Autores principales: Takamiya, Yosuke, Kobayashi, Kunihisa, Kudo, Tadachika, Okuda, Tetsu, Okamura, Keisuke, Shirai, Kazuyuki, Urata, Hidenori
Formato: Artigo
Lenguaje:Inglês
Publicado: Elmer Press 2020
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7331869/
https://ncbi.nlm.nih.gov/pubmed/32655736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr4224
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares